SinoBiomed To Conduct Clinical Trials In Thailand For China’s First Malaria Vaccine
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - SinoBiomed will conduct Phase IIb clinical trials of its recombinant malaria vaccine in Thailand in cooperation with Bangkok-based Mahidol University, the company announced Aug. 20
You may also be interested in...
Interpol Seizes Counterfeit Drugs In Southeast Asia; More Measures Mulled
The International Criminal Police Organization confiscated $6.65 million worth of counterfeit HIV/AIDS, malaria and tuberculosis drugs in Southeast Asia, the organization announced at the International Law Enforcement Training Seminar on Combating Counterfeit Drugs Nov. 17 in Phnom Penh, Cambodia
Interpol Seizes Counterfeit Drugs In Southeast Asia; More Measures Mulled
The International Criminal Police Organization confiscated $6.65 million worth of counterfeit HIV/AIDS, malaria and tuberculosis drugs in Southeast Asia, the organization announced at the International Law Enforcement Training Seminar on Combating Counterfeit Drugs Nov. 17 in Phnom Penh, Cambodia
Novartis Partners With Clinton Foundation, Indian And Chinese Drug Makers To Improve Access To Malaria Drugs
MUMBAI - Novartis and the Clinton Foundation have entered into agreements with six Indian and Chinese companies with the objective of lowering the price of malaria drugs and thereby improving access for patients in the developing and underdeveloped world